Philip Liebson to Risk Factors
This is a "connection" page, showing publications Philip Liebson has written about Risk Factors.
Connection Strength
0.335
-
Cardiovascular disease in special populations III: stroke. Prev Cardiol. 2010; 13(1):1-7.
Score: 0.055
-
Cardiovascular risk in special populations IV: Congenital heart defects. Prev Cardiol. 2010; 13(2):49-55.
Score: 0.055
-
Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
Score: 0.051
-
Cardiovascular risk in special populations: overview. Prev Cardiol. 2009; 12(3):121-7.
Score: 0.051
-
Cardiovascular risk in special populations II: hypertension. Prev Cardiol. 2009; 12(4):189-97.
Score: 0.051
-
Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans. J Am Heart Assoc. 2015 Feb 05; 4(2).
Score: 0.020
-
Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS). Am Heart J. 2009 Aug; 158(2):209-16.
Score: 0.013
-
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study. Cardiovasc Ultrasound. 2006 Nov 08; 4:43.
Score: 0.011
-
Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. Am J Cardiol. 2004 Dec 01; 94(11):1383-90.
Score: 0.010
-
Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
Score: 0.010
-
Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: the Atherosclerosis Risk in Communities (ARIC) study. Cardiovasc Ultrasound. 2003 Jun 27; 1:8.
Score: 0.009